Our study reveals a significant elevation of D-2HG levels in the serum and tumor tissues of TNBC, potentially regulated by high PHGDH expression and low D2HGDH expression, both of which correlate with poor prognosis in breast cancer. This evidence concerns the gene D2HGDH and breast carcinoma.